ASX Company Announcements


The edited text of our announcements are sourced from the Australian Stock Exchange and are delayed by at least 20 minutes. Retrieving the edited text of a company announcement indicates your acceptance of the Conditions.

Cellmid does not take any responsibility in respect of any of the edited text sourced from the Australian Stock Exchange

 

11 May 2012

ASX Announcement - Ceasing to be a substantial holder

7 May 2012

ASX Announcement - Appendix 3B

7 May 2012

ASX Announcement - Treg Antibody Patent Allowed in USA

30 April 2012

ASX Announcement - Notice of Extraordinary General Meeting / Proxy Form

26 April 2012

ASX Announcement - Appendix 4C

24 April 2012

ASX Announcement - Cellmid Completes $1.5M Placement

20 April 2012

ASX Announcement - Final Share Issue to La Jolla Cove - Appendix 3B

19 April 2012

ASX Announcement - Commercial website launched for Évolis™

18 April 2012

ASX Announcement - USA Antibody Patent for Adhesion Allowed

4 April 2012

ASX Announcement - Appendix 3B

29 March 2012

ASX Announcement - Appendix 3B

29 March 2012

ASX Announcement - Media Launch of Évolis™ Hair Products

16 March 2012

ASX Announcement - Appendix 3B

13 March 2012

ASX Announcement - Change of Director's Interest Notice

06 March 2012

ASX Announcement - Appendix 3B

05 Mar 2012

ASX Announcement - Annual Report on Celera (Quest) License

28 Feb 2012

ASX Announcement - Appendix 4D and Half Year Accounts

28 Feb 2012

ASX Announcement - Appendix 3B

20 Feb 2012

ASX Announcement - Appendix 3B

20 Feb 2012

ASX Announcement - Notice of Change of Interest of Substantial Holder

15 Feb 2012

ASX Announcement - TGA Registration and Launch of Cellmid's Évolis™ Products

13 Feb 2012

ASX Announcement - La Jolla Funding Agreement Termination

30 Jan 2012

ASX Announcement - Appendix 4C

24 Jan 2012

ASX Announcement - Appendix 3B

16 Dec 2011

ASX Announcement - Appendix 3B

8 Dec 2011

ASX Announcement - Notice of Initial Substantial Holder

8 Dec 2011

ASX Announcement - Change of Director's Interest Notice

8 Dec 2011

ASX Announcement - Change of Director's Interest Notice

8 Dec 2011

ASX Announcement - Change of Director's Interest Notice

2 Dec 2011

ASX Announcement - Dispatch of Rights Issue Holdings Statements

1 Dec 2011

ASX Announcement - Completed Midkine Study for Normal Reference Range

29 Nov 2011

ASX Announcement - Rights Issue and Placement of Shortfall

25 Nov 2011

ASX Announcement - Amended Constitution

25 Nov 2011

ASX Announcement - Results of Meeting

14 Nov 2011

ASX Announcement - US Patent for the Prevention or Treatment of Ischemia

9 Nov 2011

ASX Announcement - Non-Renounceable Rights Issue Despatch of Offer Document

31 Oct 2011

ASX Announcement - Appendix 4C

27 Oct 2011

ASX Announcement - Pro Forma Appendix 3B

26 Oct 2011

ASX Announcement - Annual Report to Shareholders

26 Oct 2011

ASX Announcement - Notice of Annual General Meeting / Proxy Form

26 Oct 2011

ASX Announcement - Non-Renounceable Rights Issue

20 Oct 2011

ASX Announcement - Amended Constitution of November 2008

12 Oct 2011

ASX Announcement - CE Marking of Cellmid's Midkine ELISA

6 Oct 2011

ASX Announcement - Completed Humanisation of First Ever Anti-midkine Antibody

30 Sept 2011

ASX Announcement - Results of meeting

30 Sept 2011

ASX Announcement - EGM Presentation by the CEO

31 Aug 2011

ASX Announcement - Notice of Extraordinary General Meeting Proxy

29 Aug 2011

ASX Announcement - Appendix 4E and Preliminary Final Report

17 Aug 2011

ASX Announcement - Change of Director's Interest Notice

 2 Aug 2011

ASX Announcement - Completed GMP Manufacture of Midkine Test

25 July 2011

ASX Announcement - Appendix 4C

10 June 2011

ASX Announcement - Appendix 3B

31 May, 2011

ASX Announcement - Change of Director's Interest Notice

25 May 2011

ASX Announcement - Celera license update

19 April 2011

ASX Announcement - Appendix 4C - quarterly

14 April 2011

ASX Announcement - Appendix 3B

13 April 2011

ASX Announcement - Cellmid Signs Antibody Humanisation Collaboration

11 April 2011

ASX Announcement - Completion of Proof of Concept Study for Heart Attack

16 April 2011

ASX Announcemnet - Appendix 3B

16 Mar 2011

ASX Announcement - Update on Cellmid's Japanese Operations

15 Mar, 2011

ASX Announcement - Change of Director's Interest Notice

07 Mar 2011

ASX Announcement - Change of Director's Interest Notice

22 Feb 2011

ASX Announcement - Cellmid News

22 Feb, 2011

ASX Announcement - Appendix 4D and Half Year Accounts

18 Feb 2011

ASX Announcement - Change of Director's Interest Notice

02 Feb 2011

ASX Announcement - Appendix 3B

31 Jan 2011

ASX Announcement - Appendix 4C - quarterly

10 Jan, 2011

ASX Announcement - Appendix 3B

05 Jan 2011

ASX Announcement - Cellmid Share Trading Policy

10 Dec 2010

ASX Announcement - Resignation of Director

08 Dec 2010

ASX Announcement - Cellmid Launches New Hair Loss Products

16 Nov 2010

ASX Announcement - Appendix 3B

15 Nov 2010

ASX Announcement - App 3Y Change in Director's Interest Notice

10 Nov 2010

ASX Announcement - Midkine Conference Results

03 Nov 2010

ASX Announcement - Results of the Annual General Meeting of Members

03 Nov, 2010

ASX Announcement - AGM Presentation

03 Nov 2010

ASX Announcement - Cellmid Launches Midkine Blood Test

27 Oct 2010

ASX Announcement - Cellmid Launches Lifesyle Subsidiary

6 Oct, 2010

ASX Announcement - Change of Company Secretary

1 Oct, 2010

ASX Announcement - Annual Report to Shareholders

1 Oct 2010

ASX Announcement - Notice of Annual General Meeting / Proxy Form

15 Sept 2010

ASX Announcement - Cellmid Secures US$8M Funding

19 Aug, 2010

ASX Announcement - Preclinical Study Shows Reduction in Disease Severity

30 July, 2010

ASX Announcement - Appendix 3B

28 July, 2010

ASX Announcement - Appendix 4C

9 July, 2010

ASX Announcement - Appendix 3B

21 April, 2010

ASX Announcement - Joint Research Agreement Signed with Kumamoto University

21 April, 2010

ASX Announcement - Appendix 4C

12 April, 2010

ASX Announcement - New Midkine Results for Heart Attack Treatment

19 Mar, 2010

ASX Announcement - Validated Cancer Marker Presentation

03 Mar, 2010

ASX Announcement - CDY Signs Collaboration for Heart Attack Treatment

25 Feb, 2010

ASX Announcement - Cellmid News

25 Feb, 2010

ASX Announcement - Appendix 4D and Half Year Accounts

19 Feb, 2010

ASX Announcement - Appendix 3B

29 Jan, 2010

ASX Announcement - Appendix 4C Quarterly Report

18 Jan, 2010

ASX Announcement - Appendix 3B New Issue

15 Dec, 2009

ASX Announcement - Notice of Ceasing to be a Substantial Holder

11 Dec, 2009

ASX Announcement - Notice of Ceasing to be a Substantial Holder

11 Dec, 2009

ASX Announcement - Notice of Change of Interest of Substantial Holder

8 Dec, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest notice

27 Nov, 2009

ASX Announcement - Appendix 3B New Issue

26 Nov, 2009

ASX Announcement - $3.63 Million Capital Raising Completed

23 Nov, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest notice

20 Nov, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest notice

20 Nov, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest notice

20 Nov, 2009

ASX Announcement - Appendix 3B New Issue

18 Nov, 2009

ASX Announcement - Change of name to Cellmid Limited

17 Nov, 2009

ASX Announcement - Results of Meeting

17 Nov, 2009

ASX Announcement - Shareholder presentation

12 Nov, 2009

ASX Announcement - Distribution agreement signed with Yamasa Corporation

29 Oct, 2009

ASX Announcement - Appendix 4C Quarterly Report

29 Oct, 2009

ASX Announcement - Lung Cancer Diagnostic License signed with Celera

16 Oct, 2009

ASX Announcment - Initial Director's Interest Notice

15 Oct, 2009

ASX Announcement - Notice of Meeting/Proxy Form

12 Oct, 2009

ASX Announcement - Appointment of non-executive Director

6 Oct, 2009

ASX Announcement - Agreement signed with Kumamoto University

8 Sept, 2009

ASX Announcement - Midkine combination test superior to conventional cancer markers

31 Aug, 2009

ASX Announcement - Appendix 4E & Annual Financial Report

24 Aug, 2009

ASX Announcement - Important European Patent Granted

3 Aug, 2009

ASX Announcement - Shares released from escrow

30 July, 2009

ASX Announcement - Appendix 4C Quarterly Report

30 July, 2009

ASX Announcement - Notice of Change of Interest of Substantial Holder

22 July, 2009

ASX Announcement - Notice of Change of Interest of Substantial Holder

7 July , 2009

ASX Announcement - Appendix 3B New Issue

7 July, 2009

ASX Announcement - Medical Therapies raised $550,000

30 June, 2009

ASX Announcement - Appendix 3B New Issue

29 June, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest notice

15 May, 2009

ASX Announcement - Appendix 3B New Issue

15 May, 2009

ASX Announcement - Analyst Report and Interactive Roadshow Released

15 May, 2009

ASX Announcment - Change in Substantial Holding

13 May, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest notice

8 May, 2009

ASX Announcement - Appendix 3B New Issue

5 May, 2009

ASX Announcement - Results of General Meeting

5 May, 2009

ASX Announcement - EGM presentation

30 April, 2009

ASX Announcement - Appendix 4C

21 April, 2009

ASX Announcement - Changes to capital raising

17 April, 2009

ASX Announcement - $700K Capital Raising Completed

2 April, 2009

ASX Announcement - Notice of General Meeting

23 March, 2009

ASX Announcement - Notice of Change of Interests of Substantial Holder

17 March, 2009

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

16 March, 2009

ASX Announcement - Appendix 3B New Issue

4 March, 2009

ASX Announcement - Notice of Initial Substantial Holder

27 Feb, 2009

ASX Announcement - Appendix 4D and Half Year Accounts

23 Feb, 2009

ASX Announcement - Appendix 3B New Issue

23 Feb, 2009

ASX Announcement - Capital Raising Completed - Convertible Notes Satisfied

18 Feb, 2009

ASX Announcement - Convertible Notes Resolved

9 Feb, 2009

ASX Announcement - Removal of $1.5M potential liability

30 Jan, 2009

ASX Announcement - Appendix 4C Quarterly Report

17 Dec, 2008

ASX Announcement - Appendix 3B New Issue

17 Dec, 2008

ASX Announcement - Share Purchase Plan

16 Dec, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

15 Dec, 2008

ASX Announcement - Funding Update

10 Dec, 2008

ASX Announcement - Changes to Senior Management

8 Dec, 2008

ASX Announcement - Midkine Test Validated

5 Dec, 2008

ASX Announcement - Share Purchase Plan Extention

28 Nov, 2008

ASX Announcement - Appendix 3B New Issue

28 Nov, 2008

ASX Announcement - Appendix 3B New Issue

24 Nov, 2008

ASX Announcement - Results of Annual General Meeting

24 Nov, 2008

ASX Announcement - Chief Executive Officer's Address to Shareholders

17 Nov, 2008

ASX Announcement - Shareholder Share Purchase Plan

31 Oct, 2008

ASX Announcement - MTY Shareholder News

31 Oct, 2008

ASX Announcement - Appendix 4C Quarterly Report

10 Oct, 2008

ASX Announcement - Resignation of Derek Bolling

3 Oct, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

17 Sept, 2008

ASX Announcement - Appendix 3B New Issue

16 Sept, 2008

ASX Announcement - Appendix 3B New Issue

15 Sept, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

10 Sept, 2008

ASX Announcement - Appointment of Director

29 Aug, 2008

ASX Announcement - Midkine Strategy

27 Aug, 2008

ASX Announcement - Appendix 4E & Annual Financial Report

26 Aug, 2008

ASX Announcement - Major USA Patent Granted

26 Aug, 2008

ASX Announcement - Director Appointment/Resignation

31 July, 2008

ASX Announcement - Appendix 4C

18 July, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

11 July, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

8 July, 2008

ASX Announcement - Appendix 3B

4 July, 2008

ASX Announcement - Appendix 3B

3 July, 2008

ASX Announcement - Completion of Settlement of the Midkine IP Agreement

20 June, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

16 June, 2008

ASX Announcement - Results of General Meeting

16 June, 2008

ASX Announcement - General Meeting Presentation

3 June, 2008

ASX Announcement - Appendix 3Y Change in Director's Interest Notice

27 May, 2008

ASX Announcement - MTY Newsletter 27 May 2008

27 May, 2008

ASX Announcement - Additional Information Midkine IP Portfolio May 2008

19 May, 2008

ASX Announcement - Notice of General Meeting

19 May, 2008

ASX Announcement - General Meeting Proxy Form

12 May, 2008

ASX Announcement - Capital Raising

9 May, 2008

ASX Announcement - Presentation on Midkine Acquisition

16 April, 2008

ASX Announcement - MTY Signs Agreement for the Acquisition of Platform Technology